Trademark: 97911835
Word
RNAIMMUNE
Status Date
Tuesday, August 6, 2024
Filing Date
Friday, April 28, 2023
Published for Opposition
Tuesday, June 11, 2024
5 vaccines for infectious disease, cancer, heart disease, and rare diseases; therapeutic preparations for the treatment of cancer, heart disease and rare hereditary and infectious diseases
44 immunotherapy, stem cell therapy, and chemotherapy for the treatment cancer, heart disease and rare hereditary and infectious diseases
The mark consists of the wording "RNAIMMUNE" inside a stylized representation of a partial double helix.
RNA IMMUNE
Color is not claimed as a feature of the mark.
May 2, 2023
New Application Entered
May 27, 2023
Notice Of Design Search Code E-Mailed
May 26, 2023
New Application Office Supplied Data Entered
Jan 25, 2024
Assigned To Examiner
May 6, 2024
Teas/Email Correspondence Entered
May 6, 2024
Correspondence Received In Law Office
May 6, 2024
Teas Response To Office Action Received
May 8, 2024
Approved For Pub - Principal Register
Feb 7, 2024
Non-Final Action Written
Feb 7, 2024
Non-Final Action E-Mailed
Feb 7, 2024
Notification Of Non-Final Action E-Mailed
May 22, 2024
Notification Of Notice Of Publication E-Mailed
Jun 11, 2024
Published For Opposition
Jun 11, 2024
Official Gazette Publication Confirmation E-Mailed
Aug 6, 2024
Noa E-Mailed - Sou Required From Applicant
Trademark Alertz updated from USPTO on 2030-01-24
